Clinical Trial Update: Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating haplo-identical transplantation with post-transplant cyclophosphamide for GVHD prophylaxis in severe aplastic anemia, hypoplas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Hypoplastic Myelodysplastic Syndrome
• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS) | Phase 2 | Status: RECRUITING